MATRIN3 (Matrin-3) is a nuclear matrix RNA-binding protein involved in nuclear organization, RNA processing, and transcription regulation. Pathogenic mutations in MATRIN3 cause familial amyotrophic lateral sclerosis (ALS) and are associated with frontotemporal dementia (FTD). MATRIN3 pathology is also observed in several neurodegenerative diseases characterized by protein inclusions [1].
¶ Domain Architecture
MATRIN3 contains multiple functional domains:
- N-terminal domain: Contains nuclear localization signal (NLS)
- RNA recognition motifs (RRMs): Two RRMs (RRM1-2) for RNA binding
- Central domain: Glycine-rich, low-complexity region
- C-terminal domain: Arginine-rich region involved in protein interactions
MATRIN3 interacts with:
- TDP-43 (TARDBP): Co-localization in nuclear speckles
- FUS: Shared nuclear matrix localization
- SMN complex: RNA processing machinery
- Various transcription factors: Gene expression regulation
MATRIN3 is a key component of the nuclear matrix:
- Nuclear scaffold: Provides structural framework for nuclear organization
- Chromatin anchoring: Facilitates chromatin positioning in the nucleus
- Nuclear speckles: Colocalizes with splicing factors in nuclear speckles
MATRIN3 participates in:
- RNA splicing: Regulation of alternative splicing
- RNA stability: Controls mRNA half-life
- Transcriptional regulation: Modulates gene expression
MATRIN3 regulates:
- Developmental genes: Important for neuronal differentiation
- Housekeeping genes: Maintains cellular function
- Stress response genes: Coordinates cellular stress responses
MATRIN3 mutations cause neurodegeneration through:
- Nuclear envelope defects: Mutations disrupt nuclear integrity
- RNA dysregulation: Altered processing of ALS-related transcripts
- Protein aggregation: Forms nuclear inclusions
- Loss of function: Impaired nuclear organization
Several MATRIN3 mutations have been identified in ALS:
- P154S: First identified mutation; affects RNA binding
- R195C: Disrupts protein interactions
- G298E: Alters nuclear localization
flowchart TD
AMATRIN3 M["utation"] --> BNuclear E["nvelope Dysfunction"]
A --> CRNA D["ysregulation"]
A --> DAltered P["rotein Interactions"]
B --> ELoss of N["uclear Integrity"]
C --> FImpaired RNA P["rocessing"]
D --> G["Aggregation with TDP-43"]
E --> HNeuronal D["eath"]
F --> H
G --> H
MATRIN3 mutations lead to:
- Nuclear envelope budding
- Nuclear membrane irregularities
- Leakage of nuclear proteins to cytoplasm
- Nuclear envelope stabilizers: Maintain nuclear integrity
- RNA processing modulators: Correct splicing defects
- Autophagy enhancers: Clear protein aggregates
- ASO therapy: Reduce mutant MATRIN3 expression
- Gene replacement: Deliver wild-type MATRIN3
- CRISPR editing: Correct pathogenic mutations
- MATRIN3 in CSF: Potential disease biomarker
- Neurofilament light chain (NfL): Disease progression marker
- Johnson et al., MATRIN3 mutations in ALS (2014)
- Taylor et al., MATRIN3 structure (2016)
- Bampton et al., MATRIN3 and TDP-43 (2019)
- Morena et al., MATRIN3 in FTD (2020)
- Gallego-Iradi et al., MATRIN3 pathology (2021)
This page was created as part of the NeuroWiki neurodegeneration protein mapping project.